In the present studies, we were unable to identify changes in GLP-1 or measures of beta-cell function after acute attenuation of postprandial bile acid absorption by the bile acid sequestrant COL, although the conclusions based on these finding may be limited by the acute dosage regimen and the inclusion of subjects without type 2 diabetes. This evidence concerns the gene GCG and type 2 diabetes mellitus.